X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (612) 612
Publication (106) 106
Book / eBook (34) 34
Book Chapter (11) 11
Book Review (7) 7
Dissertation (2) 2
Government Document (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (445) 445
index medicus (358) 358
mutation (268) 268
oncology (248) 248
cancer (246) 246
animals (223) 223
gene mutations (159) 159
genetic aspects (157) 157
research (144) 144
tumors (139) 139
signal transduction (137) 137
mice (133) 133
female (124) 124
cell biology (112) 112
proteins (108) 108
kinases (93) 93
male (93) 93
research article (91) 91
multidisciplinary sciences (90) 90
health aspects (88) 88
oncogenic mutations (86) 86
genes (81) 81
biochemistry & molecular biology (80) 80
medicine (80) 80
cell line, tumor (78) 78
oncogenic viruses (76) 76
expression (74) 74
gene expression (74) 74
middle aged (74) 74
oncogenic ras (74) 74
analysis (72) 72
biology (72) 72
article (70) 70
care and treatment (70) 70
neoplasms (70) 70
pathology (66) 66
genetics & heredity (64) 64
activation (61) 61
genetics (61) 61
development and progression (59) 59
physiological aspects (59) 59
science (59) 59
aged (57) 57
mutations (57) 57
adult (56) 56
metastasis (56) 56
apoptosis (55) 55
oncogenic kras (55) 55
cell proliferation (53) 53
gene expression regulation, neoplastic (53) 53
oncogenes (53) 53
phosphorylation (53) 53
rodents (50) 50
lung cancer (49) 49
carcinogenesis (48) 48
neoplasms - genetics (47) 47
tumorigenesis (47) 47
immunohistochemistry (46) 46
pancreatic cancer (45) 45
prognosis (44) 44
dna (43) 43
oncogenic signaling (43) 43
proto-oncogene proteins b-raf - genetics (43) 43
cell cycle (42) 42
ras proteins - genetics (41) 41
molecular cell biology (40) 40
risk factors (40) 40
kras (39) 39
review (39) 39
viruses (39) 39
cell transformation, neoplastic (38) 38
polymerase chain reaction (38) 38
signaling (37) 37
adenocarcinoma (36) 36
hematology (36) 36
medical research (36) 36
mutation - genetics (36) 36
biochemistry (35) 35
cancer therapies (35) 35
cancers and neoplasms (35) 35
melanoma (35) 35
aged, 80 and over (34) 34
base sequence (34) 34
breast-cancer (34) 34
chemotherapy (34) 34
k-ras (34) 34
molecular biology (34) 34
signaling in selected disciplines (34) 34
cells (33) 33
dna mutational analysis (33) 33
growth-factor receptor (33) 33
genomics (32) 32
medicine, research & experimental (32) 32
phenotype (32) 32
survival (32) 32
deoxyribonucleic acid--dna (31) 31
molecular targeted therapy (31) 31
braf (30) 30
breast cancer (30) 30
cell growth (30) 30
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


HUMAN MUTATION, ISSN 1059-7794, 1999, Volume 14, Issue 4, pp. 283 - 288
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2014, Volume 9, Issue 7, p. e103021
Aims: To evaluate PIK3CA gene mutations and PIK3CA expression status in Chinese esophageal squamous cell carcinoma (ESCC) patients, and their correlation with... 
BREAST-CANCER | PI3K/AKT PATHWAY | ACTIVATION | METASTASIS | MULTIDISCIPLINARY SCIENCES | CANCER-SPECIFIC MUTATIONS | TRANSCRIPTION | RECEPTOR | ONCOGENIC PI3K | FAMILY-HISTORY | EXPRESSION | Prognosis | Exons | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Esophageal Neoplasms - epidemiology | Esophageal Neoplasms - pathology | Carcinoma, Squamous Cell - diagnosis | Aged, 80 and over | Adult | Esophageal Neoplasms - diagnosis | Female | Esophageal Squamous Cell Carcinoma | Carcinoma, Squamous Cell - epidemiology | Esophagus - metabolism | China - epidemiology | Phosphatidylinositol 3-Kinases - genetics | Point Mutation | Esophagus - pathology | Class I Phosphatidylinositol 3-Kinases | Esophageal Neoplasms - genetics | Survival Analysis | Aged | Biomarkers, Tumor - genetics | Immunohistochemistry | Squamous cell carcinoma | Gene mutations | Analysis | Genes | Genetic aspects | Health aspects | Esophageal cancer | Correlation | Alcohol | Genomes | Family medical history | Metastasis | Kinases | Cancer therapies | Bioindicators | Deoxyribonucleic acid--DNA | Lymphatic system | Review boards | Therapeutic applications | Breast cancer | Radiation therapy | Gene expression | Patients | Survival | Esophagus | Studies | Pathology | Chemotherapy | Medical prognosis | Point mutation | Biomarkers | Mutation | Cancer | Deoxyribonucleic acid | DNA
Journal Article
Journal of Thoracic Disease, ISSN 2072-1439, 11/2018, Volume 10, Issue Suppl 33, pp. S4147 - S4150
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 04/2017, Volume 123, Issue 7, pp. 1166 - 1173
BACKGROUND CD5‐positive (CD5+) diffuse large B‐cell lymphoma (DLBCL) is characterized by frequent central nervous system recurrence and a predominant activated... 
CD79B | CARD11 (caspase recruitment domain family member 11) | diffuse large B‐cell lymphoma | CD5 | MYD88 (myeloid differentiation primary response 88) | diffuse large B-cell lymphoma | SURVIVAL | IDENTIFY | FREQUENT | ONCOGENIC MYD88 | L265P | diffuse large B | ONCOLOGY | cell lymphoma | HIGH PREVALENCE | EXPRESSION | TOOL | Doxorubicin - therapeutic use | Humans | Middle Aged | Male | Lymphoma, Large B-Cell, Diffuse - metabolism | Biomarkers, Tumor | Cyclophosphamide - therapeutic use | CARD Signaling Adaptor Proteins - genetics | Young Adult | Neoplasm Metastasis | DNA Mutational Analysis | Aged, 80 and over | Adult | Lymphoma, Large B-Cell, Diffuse - drug therapy | Genetic Association Studies | Myeloid Differentiation Factor 88 - genetics | Mutation Rate | CD5 Antigens - metabolism | Lymphoma, Large B-Cell, Diffuse - diagnosis | Phenotype | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Vincristine - therapeutic use | Guanylate Cyclase - genetics | Aged | CD79 Antigens - genetics | Mutation | Neoplasm Staging | Lymphoma, Large B-Cell, Diffuse - genetics | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Lymphomas | Research | Gene mutations | Membrane proteins | Central nervous system | Caspase | Lymphoma | Patients | Incidence | Recruitment | CD5 antigen | Lymphocytes B | Point mutation | MyD88 protein | Differentiation | Testes | Cancer | B-cell lymphoma
Journal Article
Journal Article
Journal Article
Journal Article